nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Rash pustular—Mesalazine—Crohn's disease	0.00733	0.00733	CcSEcCtD
Atazanavir—Rhinorrhoea—Mesalazine—Crohn's disease	0.00721	0.00721	CcSEcCtD
Atazanavir—Breast disorder—Mercaptopurine—Crohn's disease	0.00706	0.00706	CcSEcCtD
Atazanavir—Liver injury—Mesalazine—Crohn's disease	0.00694	0.00694	CcSEcCtD
Atazanavir—Amenorrhoea—Mesalazine—Crohn's disease	0.00665	0.00665	CcSEcCtD
Atazanavir—Proteinuria—Mesalazine—Crohn's disease	0.00665	0.00665	CcSEcCtD
Atazanavir—Pancreatitis—Mercaptopurine—Crohn's disease	0.00662	0.00662	CcSEcCtD
Atazanavir—Protein urine present—Mesalazine—Crohn's disease	0.00656	0.00656	CcSEcCtD
Atazanavir—Oropharyngeal pain—Mesalazine—Crohn's disease	0.00642	0.00642	CcSEcCtD
Atazanavir—Hepatocellular injury—Azathioprine—Crohn's disease	0.00641	0.00641	CcSEcCtD
Atazanavir—Cough increased—Mesalazine—Crohn's disease	0.00638	0.00638	CcSEcCtD
Atazanavir—Gout—Mesalazine—Crohn's disease	0.00626	0.00626	CcSEcCtD
Atazanavir—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00618	0.00618	CcSEcCtD
Atazanavir—Colitis—Azathioprine—Crohn's disease	0.00616	0.00616	CcSEcCtD
Atazanavir—Stomatitis—Mercaptopurine—Crohn's disease	0.00587	0.00587	CcSEcCtD
Atazanavir—Hepatocellular injury—Mesalazine—Crohn's disease	0.00584	0.00584	CcSEcCtD
Atazanavir—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0057	0.0057	CcSEcCtD
Atazanavir—Colitis—Mesalazine—Crohn's disease	0.00561	0.00561	CcSEcCtD
Atazanavir—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.00538	0.00538	CcSEcCtD
Atazanavir—Mouth ulceration—Mesalazine—Crohn's disease	0.00528	0.00528	CcSEcCtD
Atazanavir—Ecchymosis—Mesalazine—Crohn's disease	0.00528	0.00528	CcSEcCtD
Atazanavir—Immune system disorder—Mercaptopurine—Crohn's disease	0.00488	0.00488	CcSEcCtD
Atazanavir—Photosensitivity—Mesalazine—Crohn's disease	0.00483	0.00483	CcSEcCtD
Atazanavir—Gastroenteritis—Mesalazine—Crohn's disease	0.00478	0.00478	CcSEcCtD
Atazanavir—Alopecia—Mercaptopurine—Crohn's disease	0.00478	0.00478	CcSEcCtD
Atazanavir—Disorientation—Mesalazine—Crohn's disease	0.00474	0.00474	CcSEcCtD
Atazanavir—Eczema—Mesalazine—Crohn's disease	0.00472	0.00472	CcSEcCtD
Atazanavir—Blood triglycerides increased—Prednisone—Crohn's disease	0.00472	0.00472	CcSEcCtD
Atazanavir—Malnutrition—Mercaptopurine—Crohn's disease	0.00471	0.00471	CcSEcCtD
Atazanavir—Peptic ulcer—Prednisone—Crohn's disease	0.00462	0.00462	CcSEcCtD
Atazanavir—Libido decreased—Mesalazine—Crohn's disease	0.00457	0.00457	CcSEcCtD
Atazanavir—Increased appetite—Mesalazine—Crohn's disease	0.00451	0.00451	CcSEcCtD
Atazanavir—Dermatitis bullous—Mesalazine—Crohn's disease	0.00444	0.00444	CcSEcCtD
Atazanavir—Myopathy—Prednisone—Crohn's disease	0.00441	0.00441	CcSEcCtD
Atazanavir—Hepatomegaly—Prednisone—Crohn's disease	0.00437	0.00437	CcSEcCtD
Atazanavir—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00421	0.00421	CcSEcCtD
Atazanavir—Affect lability—Mesalazine—Crohn's disease	0.00417	0.00417	CcSEcCtD
Atazanavir—Mood swings—Mesalazine—Crohn's disease	0.00402	0.00402	CcSEcCtD
Atazanavir—Arthralgia—Mercaptopurine—Crohn's disease	0.00401	0.00401	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00398	0.00398	CcSEcCtD
Atazanavir—Pancreatitis—Azathioprine—Crohn's disease	0.00395	0.00395	CcSEcCtD
Atazanavir—Dry skin—Mesalazine—Crohn's disease	0.00389	0.00389	CcSEcCtD
Atazanavir—Oedema—Mercaptopurine—Crohn's disease	0.00384	0.00384	CcSEcCtD
Atazanavir—Breast disorder—Mesalazine—Crohn's disease	0.00383	0.00383	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00382	0.00382	CcSEcCtD
Atazanavir—Nasopharyngitis—Mesalazine—Crohn's disease	0.00379	0.00379	CcSEcCtD
Atazanavir—Gastritis—Mesalazine—Crohn's disease	0.00375	0.00375	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00374	0.00374	CcSEcCtD
Atazanavir—Skin disorder—Mercaptopurine—Crohn's disease	0.00373	0.00373	CcSEcCtD
Atazanavir—Abdominal distension—Mesalazine—Crohn's disease	0.00369	0.00369	CcSEcCtD
Atazanavir—Anorexia—Mercaptopurine—Crohn's disease	0.00366	0.00366	CcSEcCtD
Atazanavir—Eosinophilia—Mesalazine—Crohn's disease	0.00363	0.00363	CcSEcCtD
Atazanavir—Pancreatitis—Mesalazine—Crohn's disease	0.00359	0.00359	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00356	0.00356	CcSEcCtD
Atazanavir—Amenorrhoea—Prednisone—Crohn's disease	0.00352	0.00352	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0035	0.0035	CcSEcCtD
Atazanavir—Neutropenia—Mesalazine—Crohn's disease	0.00343	0.00343	CcSEcCtD
Atazanavir—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00339	0.00339	CcSEcCtD
Atazanavir—Pollakiuria—Mesalazine—Crohn's disease	0.00339	0.00339	CcSEcCtD
Atazanavir—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00335	0.00335	CcSEcCtD
Atazanavir—Decreased appetite—Mercaptopurine—Crohn's disease	0.00334	0.00334	CcSEcCtD
Atazanavir—Weight increased—Mesalazine—Crohn's disease	0.00334	0.00334	CcSEcCtD
Atazanavir—Weight decreased—Mesalazine—Crohn's disease	0.00332	0.00332	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00332	0.00332	CcSEcCtD
Atazanavir—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00327	0.00327	CcSEcCtD
Atazanavir—Depression—Mesalazine—Crohn's disease	0.00326	0.00326	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00324	0.00324	CcSEcCtD
Atazanavir—Renal failure—Mesalazine—Crohn's disease	0.00321	0.00321	CcSEcCtD
Atazanavir—Neuropathy peripheral—Mesalazine—Crohn's disease	0.0032	0.0032	CcSEcCtD
Atazanavir—Jaundice—Mesalazine—Crohn's disease	0.00319	0.00319	CcSEcCtD
Atazanavir—Stomatitis—Mesalazine—Crohn's disease	0.00319	0.00319	CcSEcCtD
Atazanavir—Urinary tract infection—Mesalazine—Crohn's disease	0.00318	0.00318	CcSEcCtD
Atazanavir—Sweating—Mesalazine—Crohn's disease	0.00313	0.00313	CcSEcCtD
Atazanavir—Haematuria—Mesalazine—Crohn's disease	0.00312	0.00312	CcSEcCtD
Atazanavir—Hiccups—Prednisone—Crohn's disease	0.00309	0.00309	CcSEcCtD
Atazanavir—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00309	0.00309	CcSEcCtD
Atazanavir—Erythema multiforme—Azathioprine—Crohn's disease	0.00305	0.00305	CcSEcCtD
Atazanavir—Body temperature increased—Mercaptopurine—Crohn's disease	0.00304	0.00304	CcSEcCtD
Atazanavir—Fluid retention—Prednisone—Crohn's disease	0.00293	0.00293	CcSEcCtD
Atazanavir—Hepatitis—Mesalazine—Crohn's disease	0.00293	0.00293	CcSEcCtD
Atazanavir—Immune system disorder—Azathioprine—Crohn's disease	0.00291	0.00291	CcSEcCtD
Atazanavir—Mediastinal disorder—Azathioprine—Crohn's disease	0.0029	0.0029	CcSEcCtD
Atazanavir—Urinary tract disorder—Mesalazine—Crohn's disease	0.0029	0.0029	CcSEcCtD
Atazanavir—Oedema peripheral—Mesalazine—Crohn's disease	0.00289	0.00289	CcSEcCtD
Atazanavir—Connective tissue disorder—Mesalazine—Crohn's disease	0.00288	0.00288	CcSEcCtD
Atazanavir—Urethral disorder—Mesalazine—Crohn's disease	0.00288	0.00288	CcSEcCtD
Atazanavir—Alopecia—Azathioprine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Atazanavir—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00283	0.00283	CcSEcCtD
Atazanavir—Oesophagitis—Prednisone—Crohn's disease	0.00282	0.00282	CcSEcCtD
Atazanavir—Ecchymosis—Prednisone—Crohn's disease	0.00279	0.00279	CcSEcCtD
Atazanavir—Erythema multiforme—Mesalazine—Crohn's disease	0.00277	0.00277	CcSEcCtD
Atazanavir—Eye disorder—Mesalazine—Crohn's disease	0.00274	0.00274	CcSEcCtD
Atazanavir—Tinnitus—Mesalazine—Crohn's disease	0.00274	0.00274	CcSEcCtD
Atazanavir—Cardiac disorder—Mesalazine—Crohn's disease	0.00272	0.00272	CcSEcCtD
Atazanavir—Hyperkinesia—Prednisone—Crohn's disease	0.0027	0.0027	CcSEcCtD
Atazanavir—Angiopathy—Mesalazine—Crohn's disease	0.00266	0.00266	CcSEcCtD
Atazanavir—Immune system disorder—Mesalazine—Crohn's disease	0.00265	0.00265	CcSEcCtD
Atazanavir—Mediastinal disorder—Mesalazine—Crohn's disease	0.00264	0.00264	CcSEcCtD
Atazanavir—Diarrhoea—Mercaptopurine—Crohn's disease	0.00263	0.00263	CcSEcCtD
Atazanavir—Ill-defined disorder—Azathioprine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Atazanavir—Alopecia—Mesalazine—Crohn's disease	0.00259	0.00259	CcSEcCtD
Atazanavir—Diabetes mellitus—Prednisone—Crohn's disease	0.00258	0.00258	CcSEcCtD
Atazanavir—Mental disorder—Mesalazine—Crohn's disease	0.00257	0.00257	CcSEcCtD
Atazanavir—Malaise—Azathioprine—Crohn's disease	0.00253	0.00253	CcSEcCtD
Atazanavir—Flatulence—Mesalazine—Crohn's disease	0.00252	0.00252	CcSEcCtD
Atazanavir—Vascular purpura—Prednisone—Crohn's disease	0.00251	0.00251	CcSEcCtD
Atazanavir—Tension—Mesalazine—Crohn's disease	0.00251	0.00251	CcSEcCtD
Atazanavir—Dysgeusia—Mesalazine—Crohn's disease	0.0025	0.0025	CcSEcCtD
Atazanavir—Nervousness—Mesalazine—Crohn's disease	0.00248	0.00248	CcSEcCtD
Atazanavir—Back pain—Mesalazine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Atazanavir—Vomiting—Mercaptopurine—Crohn's disease	0.00244	0.00244	CcSEcCtD
Atazanavir—Rash—Mercaptopurine—Crohn's disease	0.00242	0.00242	CcSEcCtD
Atazanavir—Dermatitis—Mercaptopurine—Crohn's disease	0.00242	0.00242	CcSEcCtD
Atazanavir—Increased appetite—Prednisone—Crohn's disease	0.00239	0.00239	CcSEcCtD
Atazanavir—Amnesia—Prednisone—Crohn's disease	0.00239	0.00239	CcSEcCtD
Atazanavir—Myalgia—Azathioprine—Crohn's disease	0.00239	0.00239	CcSEcCtD
Atazanavir—Arthralgia—Azathioprine—Crohn's disease	0.00239	0.00239	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00237	0.00237	CcSEcCtD
Atazanavir—Ill-defined disorder—Mesalazine—Crohn's disease	0.00237	0.00237	CcSEcCtD
Atazanavir—Discomfort—Azathioprine—Crohn's disease	0.00236	0.00236	CcSEcCtD
Atazanavir—Angioedema—Mesalazine—Crohn's disease	0.00233	0.00233	CcSEcCtD
Atazanavir—Purpura—Prednisone—Crohn's disease	0.00233	0.00233	CcSEcCtD
Atazanavir—Malaise—Mesalazine—Crohn's disease	0.0023	0.0023	CcSEcCtD
Atazanavir—Syncope—Mesalazine—Crohn's disease	0.00229	0.00229	CcSEcCtD
Atazanavir—Nausea—Mercaptopurine—Crohn's disease	0.00228	0.00228	CcSEcCtD
Atazanavir—Infection—Azathioprine—Crohn's disease	0.00227	0.00227	CcSEcCtD
Atazanavir—Palpitations—Mesalazine—Crohn's disease	0.00226	0.00226	CcSEcCtD
Atazanavir—Loss of consciousness—Mesalazine—Crohn's disease	0.00224	0.00224	CcSEcCtD
Atazanavir—Cough—Mesalazine—Crohn's disease	0.00223	0.00223	CcSEcCtD
Atazanavir—Skin disorder—Azathioprine—Crohn's disease	0.00222	0.00222	CcSEcCtD
Atazanavir—Affect lability—Prednisone—Crohn's disease	0.00221	0.00221	CcSEcCtD
Atazanavir—Hypertension—Mesalazine—Crohn's disease	0.00221	0.00221	CcSEcCtD
Atazanavir—Psychotic disorder—Prednisone—Crohn's disease	0.00219	0.00219	CcSEcCtD
Atazanavir—Arthralgia—Mesalazine—Crohn's disease	0.00217	0.00217	CcSEcCtD
Atazanavir—Chest pain—Mesalazine—Crohn's disease	0.00217	0.00217	CcSEcCtD
Atazanavir—Myalgia—Mesalazine—Crohn's disease	0.00217	0.00217	CcSEcCtD
Atazanavir—Anxiety—Mesalazine—Crohn's disease	0.00217	0.00217	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00216	0.00216	CcSEcCtD
Atazanavir—Discomfort—Mesalazine—Crohn's disease	0.00215	0.00215	CcSEcCtD
Atazanavir—Cardiac arrest—Prednisone—Crohn's disease	0.00213	0.00213	CcSEcCtD
Atazanavir—Dry mouth—Mesalazine—Crohn's disease	0.00213	0.00213	CcSEcCtD
Atazanavir—Mood swings—Prednisone—Crohn's disease	0.00213	0.00213	CcSEcCtD
Atazanavir—Confusional state—Mesalazine—Crohn's disease	0.0021	0.0021	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00208	0.00208	CcSEcCtD
Atazanavir—Oedema—Mesalazine—Crohn's disease	0.00208	0.00208	CcSEcCtD
Atazanavir—Infection—Mesalazine—Crohn's disease	0.00207	0.00207	CcSEcCtD
Atazanavir—Dry skin—Prednisone—Crohn's disease	0.00206	0.00206	CcSEcCtD
Atazanavir—Shock—Mesalazine—Crohn's disease	0.00205	0.00205	CcSEcCtD
Atazanavir—Nervous system disorder—Mesalazine—Crohn's disease	0.00204	0.00204	CcSEcCtD
Atazanavir—Skin disorder—Mesalazine—Crohn's disease	0.00202	0.00202	CcSEcCtD
Atazanavir—Hyperhidrosis—Mesalazine—Crohn's disease	0.00202	0.00202	CcSEcCtD
Atazanavir—Anorexia—Mesalazine—Crohn's disease	0.00199	0.00199	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00198	0.00198	CcSEcCtD
Atazanavir—Muscular weakness—Prednisone—Crohn's disease	0.00198	0.00198	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00198	0.00198	CcSEcCtD
Atazanavir—Abdominal distension—Prednisone—Crohn's disease	0.00195	0.00195	CcSEcCtD
Atazanavir—Pancreatitis—Prednisone—Crohn's disease	0.0019	0.0019	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.0019	0.0019	CcSEcCtD
Atazanavir—Feeling abnormal—Azathioprine—Crohn's disease	0.00189	0.00189	CcSEcCtD
Atazanavir—Insomnia—Mesalazine—Crohn's disease	0.00189	0.00189	CcSEcCtD
Atazanavir—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00187	0.00187	CcSEcCtD
Atazanavir—Dyspnoea—Mesalazine—Crohn's disease	0.00186	0.00186	CcSEcCtD
Atazanavir—Somnolence—Mesalazine—Crohn's disease	0.00185	0.00185	CcSEcCtD
Atazanavir—Dyspepsia—Mesalazine—Crohn's disease	0.00183	0.00183	CcSEcCtD
Atazanavir—Neutropenia—Prednisone—Crohn's disease	0.00181	0.00181	CcSEcCtD
Atazanavir—Decreased appetite—Mesalazine—Crohn's disease	0.00181	0.00181	CcSEcCtD
Atazanavir—Body temperature increased—Azathioprine—Crohn's disease	0.00181	0.00181	CcSEcCtD
Atazanavir—Abdominal pain—Azathioprine—Crohn's disease	0.00181	0.00181	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.0018	0.0018	CcSEcCtD
Atazanavir—Fatigue—Mesalazine—Crohn's disease	0.0018	0.0018	CcSEcCtD
Atazanavir—Erectile dysfunction—Prednisone—Crohn's disease	0.00179	0.00179	CcSEcCtD
Atazanavir—Pain—Mesalazine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Atazanavir—Constipation—Mesalazine—Crohn's disease	0.00178	0.00178	CcSEcCtD
Atazanavir—Weight increased—Prednisone—Crohn's disease	0.00176	0.00176	CcSEcCtD
Atazanavir—Weight decreased—Prednisone—Crohn's disease	0.00175	0.00175	CcSEcCtD
Atazanavir—Hyperglycaemia—Prednisone—Crohn's disease	0.00175	0.00175	CcSEcCtD
Atazanavir—Depression—Prednisone—Crohn's disease	0.00172	0.00172	CcSEcCtD
Atazanavir—Feeling abnormal—Mesalazine—Crohn's disease	0.00172	0.00172	CcSEcCtD
Atazanavir—Gastrointestinal pain—Mesalazine—Crohn's disease	0.0017	0.0017	CcSEcCtD
Atazanavir—Neuropathy peripheral—Prednisone—Crohn's disease	0.00169	0.00169	CcSEcCtD
Atazanavir—Hypersensitivity—Azathioprine—Crohn's disease	0.00169	0.00169	CcSEcCtD
Atazanavir—Urticaria—Mesalazine—Crohn's disease	0.00166	0.00166	CcSEcCtD
Atazanavir—Body temperature increased—Mesalazine—Crohn's disease	0.00165	0.00165	CcSEcCtD
Atazanavir—Abdominal pain—Mesalazine—Crohn's disease	0.00165	0.00165	CcSEcCtD
Atazanavir—Diarrhoea—Azathioprine—Crohn's disease	0.00157	0.00157	CcSEcCtD
Atazanavir—Hallucination—Prednisone—Crohn's disease	0.00154	0.00154	CcSEcCtD
Atazanavir—Hypersensitivity—Mesalazine—Crohn's disease	0.00154	0.00154	CcSEcCtD
Atazanavir—Connective tissue disorder—Prednisone—Crohn's disease	0.00153	0.00153	CcSEcCtD
Atazanavir—Dizziness—Azathioprine—Crohn's disease	0.00151	0.00151	CcSEcCtD
Atazanavir—Asthenia—Mesalazine—Crohn's disease	0.0015	0.0015	CcSEcCtD
Atazanavir—Pruritus—Mesalazine—Crohn's disease	0.00147	0.00147	CcSEcCtD
Atazanavir—Vomiting—Azathioprine—Crohn's disease	0.00145	0.00145	CcSEcCtD
Atazanavir—Eye disorder—Prednisone—Crohn's disease	0.00145	0.00145	CcSEcCtD
Atazanavir—Rash—Azathioprine—Crohn's disease	0.00144	0.00144	CcSEcCtD
Atazanavir—Dermatitis—Azathioprine—Crohn's disease	0.00144	0.00144	CcSEcCtD
Atazanavir—Headache—Azathioprine—Crohn's disease	0.00143	0.00143	CcSEcCtD
Atazanavir—Diarrhoea—Mesalazine—Crohn's disease	0.00143	0.00143	CcSEcCtD
Atazanavir—Angiopathy—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Atazanavir—Immune system disorder—Prednisone—Crohn's disease	0.0014	0.0014	CcSEcCtD
Atazanavir—Dizziness—Mesalazine—Crohn's disease	0.00138	0.00138	CcSEcCtD
Atazanavir—Alopecia—Prednisone—Crohn's disease	0.00137	0.00137	CcSEcCtD
Atazanavir—Mental disorder—Prednisone—Crohn's disease	0.00136	0.00136	CcSEcCtD
Atazanavir—Nausea—Azathioprine—Crohn's disease	0.00136	0.00136	CcSEcCtD
Atazanavir—Malnutrition—Prednisone—Crohn's disease	0.00135	0.00135	CcSEcCtD
Atazanavir—Vomiting—Mesalazine—Crohn's disease	0.00133	0.00133	CcSEcCtD
Atazanavir—Rash—Mesalazine—Crohn's disease	0.00131	0.00131	CcSEcCtD
Atazanavir—Dermatitis—Mesalazine—Crohn's disease	0.00131	0.00131	CcSEcCtD
Atazanavir—Headache—Mesalazine—Crohn's disease	0.00131	0.00131	CcSEcCtD
Atazanavir—Ill-defined disorder—Prednisone—Crohn's disease	0.00125	0.00125	CcSEcCtD
Atazanavir—Agitation—Prednisone—Crohn's disease	0.00124	0.00124	CcSEcCtD
Atazanavir—Nausea—Mesalazine—Crohn's disease	0.00124	0.00124	CcSEcCtD
Atazanavir—Angioedema—Prednisone—Crohn's disease	0.00123	0.00123	CcSEcCtD
Atazanavir—Malaise—Prednisone—Crohn's disease	0.00122	0.00122	CcSEcCtD
Atazanavir—Syncope—Prednisone—Crohn's disease	0.00121	0.00121	CcSEcCtD
Atazanavir—Loss of consciousness—Prednisone—Crohn's disease	0.00119	0.00119	CcSEcCtD
Atazanavir—Convulsion—Prednisone—Crohn's disease	0.00117	0.00117	CcSEcCtD
Atazanavir—Hypertension—Prednisone—Crohn's disease	0.00117	0.00117	CcSEcCtD
Atazanavir—Arthralgia—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Atazanavir—Myalgia—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Atazanavir—Anxiety—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00114	0.00114	CcSEcCtD
Atazanavir—Discomfort—Prednisone—Crohn's disease	0.00114	0.00114	CcSEcCtD
Atazanavir—Oedema—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Atazanavir—Infection—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Atazanavir—Shock—Prednisone—Crohn's disease	0.00109	0.00109	CcSEcCtD
Atazanavir—Nervous system disorder—Prednisone—Crohn's disease	0.00108	0.00108	CcSEcCtD
Atazanavir—Skin disorder—Prednisone—Crohn's disease	0.00107	0.00107	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisone—Crohn's disease	0.00107	0.00107	CcSEcCtD
Atazanavir—Anorexia—Prednisone—Crohn's disease	0.00105	0.00105	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.001	0.001	CcSEcCtD
Atazanavir—Insomnia—Prednisone—Crohn's disease	0.000997	0.000997	CcSEcCtD
Atazanavir—Dyspepsia—Prednisone—Crohn's disease	0.000971	0.000971	CcSEcCtD
Atazanavir—Decreased appetite—Prednisone—Crohn's disease	0.000959	0.000959	CcSEcCtD
Atazanavir—Fatigue—Prednisone—Crohn's disease	0.000951	0.000951	CcSEcCtD
Atazanavir—Constipation—Prednisone—Crohn's disease	0.000943	0.000943	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisone—Crohn's disease	0.000909	0.000909	CcSEcCtD
Atazanavir—Gastrointestinal pain—Prednisone—Crohn's disease	0.000902	0.000902	CcSEcCtD
Atazanavir—Urticaria—Prednisone—Crohn's disease	0.000876	0.000876	CcSEcCtD
Atazanavir—Abdominal pain—Prednisone—Crohn's disease	0.000872	0.000872	CcSEcCtD
Atazanavir—Body temperature increased—Prednisone—Crohn's disease	0.000872	0.000872	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisone—Crohn's disease	0.000813	0.000813	CcSEcCtD
Atazanavir—Asthenia—Prednisone—Crohn's disease	0.000791	0.000791	CcSEcCtD
Atazanavir—Pruritus—Prednisone—Crohn's disease	0.00078	0.00078	CcSEcCtD
Atazanavir—Diarrhoea—Prednisone—Crohn's disease	0.000755	0.000755	CcSEcCtD
Atazanavir—Dizziness—Prednisone—Crohn's disease	0.000729	0.000729	CcSEcCtD
Atazanavir—Vomiting—Prednisone—Crohn's disease	0.000701	0.000701	CcSEcCtD
Atazanavir—Rash—Prednisone—Crohn's disease	0.000695	0.000695	CcSEcCtD
Atazanavir—Dermatitis—Prednisone—Crohn's disease	0.000695	0.000695	CcSEcCtD
Atazanavir—Headache—Prednisone—Crohn's disease	0.000691	0.000691	CcSEcCtD
Atazanavir—Nausea—Prednisone—Crohn's disease	0.000655	0.000655	CcSEcCtD
